QualitecFarma Strengthens Global Reach with New UK Office to Enhance Clinical Research Services
Situated in London, the UK office is ideally positioned to strengthen our engagement with the global clinical research community.
As part of our ongoing commitment to expanding our global operations and enhancing clinical research support for our clients, QualitecFarma, a full-service Contract Research Organization (CRO) with headquarters in Madrid and presence in the United States, is proud to announce the opening of a new branch office in the United Kingdom.
This strategic move enhances our ability to provide dedicated support to the bio-pharmaceutical industry. Situated in London, the UK office is ideally positioned to strengthen our engagement with the global clinical research community.
The new location will serve as a central hub for client relations, regulatory liaison, and project coordination, ensuring that our clients receive the personalized, high-quality support they need throughout the clinical trial process.
“Our UK office marks a significant milestone in our global growth strategy,” said Óscar Mesa, QualitecFarma’s CEO. “Being closer to our clients enables us to deliver timely and efficient support, fostering stronger collaborations and helping them navigate the complexities of clinical research.”
The UK office will work closely with our headquarters in Madrid and our US office to enhance client relations and streamline project coordination. This integrated approach ensures that our clients benefit from our global expertise while receiving the localized attention necessary for success in European markets.
For more information about how we can support your clinical research needs, visit www.qualitecfarma.com.